Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Chaux

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Immunology|July 17, 2012
HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individualsClaire Ventura, Hélène Bisceglia, Yves Girerd-Chambaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 proteinYi Zhang, Pascal Chaux, Vincent Stroobant, et al.
Immunological Reviews|November 26, 2002
Tumor-specific shared antigenic peptides recognized by human T cellsPierre Van Der Bruggen, Yi Zhang, Pascal Chaux, et al.
Blood|October 24, 2002
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia AMarc Jacquemin, Valérie Vantomme, Cécile Buhot, et al.
Diabetologia|November 6, 2014
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse modelsPär G Larsson, Tadepally Lakshmikanth, Olli H Laitinen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Immunology|July 17, 2012
HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individualsClaire Ventura, Hélène Bisceglia, Yves Girerd-Chambaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 proteinYi Zhang, Pascal Chaux, Vincent Stroobant, et al.
Immunological Reviews|November 26, 2002
Tumor-specific shared antigenic peptides recognized by human T cellsPierre Van Der Bruggen, Yi Zhang, Pascal Chaux, et al.
Blood|October 24, 2002
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia AMarc Jacquemin, Valérie Vantomme, Cécile Buhot, et al.
Diabetologia|November 6, 2014
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse modelsPär G Larsson, Tadepally Lakshmikanth, Olli H Laitinen, et al.
Pageof 1